Sector
PharmaceuticalsOpen
₹99Prev. Close
₹99.56Turnover(Lac.)
₹1.44Day's High
₹101.4Day's Low
₹9952 Week's High
₹247.452 Week's Low
₹84.27Book Value
₹42.75Face Value
₹10Mkt Cap (₹ Cr.)
139.61P/E
27.2EPS
3.66Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 12.59 | 12.59 | 12.59 | 12.04 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 34.51 | 27.97 | 26.7 | 23.05 |
Net Worth | 47.1 | 40.56 | 39.29 | 35.09 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 45.93 | 34.96 | 40.04 | 31.1 |
yoy growth (%) | 31.39 | -12.69 | 28.75 | -12.77 |
Raw materials | -7.57 | -5.17 | -6.97 | -5.71 |
As % of sales | 16.49 | 14.79 | 17.41 | 18.36 |
Employee costs | -13.73 | -12.11 | -13.2 | -9.95 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 3.16 | -3.27 | 0.09 | -2.77 |
Depreciation | -4.55 | -4.35 | -3.9 | -3.59 |
Tax paid | -0.71 | 0.79 | -0.02 | 1.44 |
Working capital | 0.04 | 1.69 | 5.05 | 2.96 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 31.39 | -12.69 | 28.75 | -12.77 |
Op profit growth | 97.03 | -32.85 | 64.98 | -50.64 |
EBIT growth | 280.34 | -61.5 | 110.47 | -69.56 |
Net profit growth | -198.94 | -3,536.19 | -105.42 | -147.74 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Atul Maheshwari
Whole Time Director & CFO
S M Maheshwari
Independent Non Exe. Director
Dhaval J Soni
Independent Director
Chandramohan Bhagavatula
Independent Director
NANDAN SRINATH
Company Sec. & Compli. Officer
Ritesh Pandey.
Survey No 6,
Village Poicha (Rania) Savli,
Gujarat - 391780
Tel: 91-02667-244308/244729
Website: http://www.lactoseindialimited.com
Email: lil@lactoseindialimited.com, cs.lactose@gmail.com
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. ...
Read More
Reports by Lactose (India) Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.